Quote:Oops
I swear that the 'Oops' is the actual lead in from the article.![]()
Rudy Giuliani May Have Accidentally Outed Trump for Breaking the Law Over Michael Cohen and Stormy Daniels
Rudy Giuliani went on Fox News to get Trump out of trouble, but may have just given the president a whole new set of problems with federal ethics rules.
Lachlan Markay
05.03.18 12:24 PM ET
![]()
Rudy Giuliani may have put his new client, the President of the United States, in a bad spot.
In attempting to head off allegations of illegal fundraising, he may have implicated Trump in an entirely different violation of federal law.
In Fox News interviews on Wednesday night and Thursday morning, Giuliani disclosed, among other pertinent details, that hush money paid to the porn star Stormy Daniels in October 2016 came from Trump’s personal attorney, Michael Cohen.
But contrary to past claims by Trump and his former attorney, Giuliani said in an interview with Sean Hannity, Trump reimbursed him for the $130,000 paid to ensure Daniels’ silence on her alleged affair with the president.
This explanation would, in theory, head off allegations that the $130,000 amounted to an illegal contribution to Trump’s campaign. But in detailing the structure of the payments, Giuliani may have admitted that Trump fudged federal ethics paperwork—paperwork that his lawyers tried, unsuccessfully, to keep Trump from swearing was true and accurate.
By Giuliani’s account, Cohen’s payment to Daniels was effectively a loan, as he knew it would be repaid per the terms of his agreement with Trump. Giuliani insists that it was not a loan to the campaign, which would have amounted to an illegal contribution.
Trump’s repayment was entirely a personal expense designed to avoid personal embarrassment, Giuliani explained. Hence, Cohen’s payment was in effect a loan to Trump personally, which Trump would later repay.
Framing the payment that way could head off allegations of campaign finance violations, though even that is not clear. But Giuliani’s position could be lose-lose for Trump.
“If [the] Cohen loan was not one to [the] campaign, then it was one to you, and you omitted it from your personal federal financial disclosures for the period,” noted Norm Eisen, a former White House ethics lawyer, in a tweet on Thursday. “That’s a crime under 18 USC 1001 & we have filed a criminal complaint with DOJ.”
The complaint, filed by Eisen’s left-leaning group Citizens for Responsibility and Ethics in Washington in March, cited media reports surrounding Cohen’s payment to Daniels.
Those reports, effectively confirmed by Giuliani on Thursday, indicated the payments amounted to a financial liability. But such a liability was not disclosed in Trump’s personal financial statements filed with federal ethics officials last year.
Under the Ethics in Government Act, most federal officeholders, including the president, must file annual reports that give a full accounting of their finances, including income, assets, and liabilities, among other information.
The report that Trump filed last year disclosed no debts owed to either Cohen or Essential Consultants LLC, the company he used to make payments to Daniels.
“The parties involved in the transaction apparently took extreme measures to ensure that their identities would not be disclosed,” CREW wrote in its complaint to the Justice Department and the Office of Government Ethics. “These facts suggest President Trump's failure to report the loan may have been done both knowingly and willfully.”
In April, as Trump’s attorneys gathered information for a financial disclosure report covering 2016 and early 2017, those attorneys met with officials from the Office of Government Ethics.
At that meeting, according to correspondence subsequently reported by the Associated Press, Trump’s attorneys requested that Trump be excused from legally certifying that the disclosure of his assets and liabilities was accurate and complete. OGE balked and required that he do so.
Oops I swear that the 'Oops' is the actual lead in from
Top 10 Most Recent News Articles
DataBeyond Puts AI Sorting Before a Waste Mountain
Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...
Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle
Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...
Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure
Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...
Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint
A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...
Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis
A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...
Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era
A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...
Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock
August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...
Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims
Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...
Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull
A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...
Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look
Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...
Continue ReadingTop 5 Most Recently Viewed Articles
Dollar Tree's Earnings Drop and Future Outlook Challenges
Highlights from Dollar Tree's Earnings Report Dollar Tree has encountered significant challenges in the market after revealing that its second-quarter earnings did not meet analysts' expectations. The discount retailer reported a year-over-year decline in net income, attributing this downturn to the considerable difficulties posed by the current economic conditions. This...
Continue Reading
The Risks of Banking Standards: A Deep Dive into Safety
Understanding Current Banking Risks Banks are integral to the economy, ensuring that funds flow smoothly throughout various sectors. However, recent decisions to relax standards for banks have raised significant concerns about potential risks that may arise. Weiss Ratings, a prominent name in independent bank safety evaluations, has recently highlighted unsettling changes...
Continue Reading
Koch and OCP Forge Ahead with New Joint Venture
Tying Two Giants Together When industrial titans like Koch Ag & Energy Solutions and Moroccan powerhouse OCP decide to double down on their existing partnership, anyone with a stake in iron and fertilizer industries ought to take note. It's not every day that two behemoth corporations decide to lace up together in a joint venture, signaling a potential shift in market...
Continue Reading
Youlife Group Inc. Moves to Expand with Strategic Acquisitions
Youlife Group Inc. Expands Market Reach with Key Acquisitions Youlife Group Inc. (NASDAQ: YOU), recognized as a leading provider of blue-collar lifetime services, has exciting plans to make strategic acquisitions aimed at bolstering its market position. This initiative comes as Youlife enters into non-binding term sheets with the controlling shareholders of four notable...
Continue Reading
Advancements in Wet AMD Treatment: Outlook Therapeutics Updates
Significant Milestones for Outlook Therapeutics ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a pioneering biopharmaceutical company, has made notable strides towards securing regulatory approval for its innovative treatment for wet age-related macular degeneration (wet AMD). Their investigational product, ONS-5010 (bevacizumab-vikg), is an ophthalmic...
Continue Reading